相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study
Kathryn Connelly et al.
ARTHRITIS & RHEUMATOLOGY (2023)
Measurement of specific organ domains in lupus randomized controlled trials: a scoping review
Kathryn Connelly et al.
RHEUMATOLOGY (2022)
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study
Rangi Kandane-Rathnayake et al.
Lancet Rheumatology (2022)
Clinician-reported outcome measures in lupus trials: a problem worth solving
Kathryn Connelly et al.
LANCET RHEUMATOLOGY (2021)
The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus
Helena Enocsson et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Brad H. Rovin et al.
LANCET (2021)
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis
Irene B. Murimi-Worstell et al.
BMJ OPEN (2020)
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis
Gabriella Moroni et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients
D. Jesus et al.
LUPUS (2019)
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes
Meggan Mackay et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Development of the Asia Pacific Lupus Collaboration cohort
Rangi Kandane-Rathnayake et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Vera Golder et al.
LANCET RHEUMATOLOGY (2019)
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1) a randomised, controlled, phase 3 trial
Richard A. Furie et al.
LANCET RHEUMATOLOGY (2019)
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index
Kenneth C. Kalunian et al.
RHEUMATOLOGY (2018)
Systemic Lupus Erythematosus (SLE) Responder Index response is associated with global benefit for patients with SLE
R. Furie et al.
LUPUS (2018)
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Kate Franklyn et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?
A. Dima et al.
LUPUS (2016)
Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials
Kristin M. Corapi et al.
ARTHRITIS RESEARCH & THERAPY (2015)
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
Farah Tamirou et al.
LUPUS SCIENCE & MEDICINE (2015)
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Daniel J. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
Richard A. Furie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
C-Reactive Protein and Systemic Lupus Erythematosus
Shilpa Gaitonde et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
DA Isenberg et al.
RHEUMATOLOGY (2005)
分享论文
